Growth dependency of a new human pancreatic cancer cell line, YAPC, on autocrine interleukin-1α stimulation

International Journal of Cancer

Volumn 76, Issue 1, 1998, Pages 141-147

  Yamada, Takayuki ^a   Okajima, Fumikazu ^a   Adachi, Masakazu ^b   Ohwada, Susumu ^a   Kondo, Yoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 8; MITOMYCIN C;

ADULT; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CANCER INHIBITION; CASE REPORT; CELL GROWTH; CELL INTERACTION; CELL KINETICS; CELL STIMULATION; CLINICAL TRIAL; CYTOKINE RELEASE; DNA SYNTHESIS; DOSE RESPONSE; GROWTH REGULATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; ANIMALS; CELL CYCLE; CELL DIVISION; CELL LINE; CHROMOSOME ABERRATIONS; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; CYTOKINES; DISEASE PROGRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-1; INTERLEUKINS; KARYOTYPING; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031959588     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980330)76:1<141::AID-IJC22>3.0.CO;2-E     Document Type: Article

References (20)

1. BANSAL, P. and SONNENBERG, A., Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology, 109, 247-251 (1995).
2. BASSO, D., PLEBANI, M., FOGAR, P., PANOZZO, M.P., MEGGIATO, T., DE PAOLI, M. and DEL FAVERO, G., Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes. Int. J. clin. Lab. Res, 25, 40-43 (1995).
3. BUZDAR, A.U., SMITH, R., VOGEL, C., BONOMI, P., KELLER, A.M., FAVIS, G., MULAGHA, M. and COOPER, J., Fadrozole-HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials. Cancer, 77, 2503-2513 (1996).
4. CHEN, J., KARAKASHIAN, M.N., MERRILL, JR, A.H., and MORGAN, E.T., Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J. biol. Chem., 270, 2523-25238 (1995).
5. CHOMIENNE, C., FENAUX, P. and DEGOS, L., Retinoid differentiation therapy in promyelocytic leukemia. FASEB J., 10, 1025-1030 (1996).
6. DANFORTH, D.N., JR. and SGAGIAS, M.K., Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res., 53, 1538-1545 (1993).
7. DRESSLER, K.A., MATHIAS, S. and KOLESNICK, R.N., Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science, 255, 1715-1718 (1992).
8. GRESS, T.M., MULLER PILLASCH, F., LERCH, M.M., FRIESS, H., BÜCHLER, M. and ADLER, G., Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer, 62, 407-413 (1995).
9. HILBERT, D.M., KOPF, M., MOCK, B.A., KOHLER, G. and RUDIKOFF, S., Interleukin 6 is essential for in vivo development of B lineage neoplasms. J. exp. Med., 182, 243-248 (1995).
10. HITZLER, J.K., MARTINEZ VALDEZ, H., BERGSAGEL, D.B., MINDEN, M.D. and MESSNER, H.A., Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease. Blood, 78, 1996-2004 (1991).
11. ITO, R., KITADAI, Y., KYO, E., YOKOZAKI, H., YASUI, W., YAMASHITA, U., NIKAI, H. and TAMARA, E., Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells. Cancer Res., 53, 4102-4106 (1993).
12. KISHIMOTO, T., ISHIKURA, H., KIMURA, C. TAKAHASHI, T., KATO, H. and YOSHIKI, T., Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int. J. Cancer, 69, 290-294 (1996).
13. KOCH, I., DEPENBROCK, H., DANHAUSER RIEDL, S., RASTETTER, J.W. and Hanauske, A.R., Interleukin 1 modulates growth of human renal carcinoma cells in vitro. Brit. J. Cancer, 71, 794-800 (1995).
14. KUREBAYASHI, J., KUROSUMI, M. and SONOO, H., A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice. Brit. J. Cancer, 74, 200-207 (1996).
15. LOWENFELS, A.B., MAISONNEUVE, P., CAVALLINI, G., AMMANN, R.W., LANKISCH, P.G., ANDERSEN, J.R., DIMAGNO, E.P., ANDREN SANDBERG, A. and DOMELLOF, L., Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med., 328, 1433-1437 (1993).
16. MUTHUKKUMAR, S., SELLS, S.F., GRIST, S.A. and RANGNEKAR, V.M., Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB. J. biol. Chem., 271, 5733-5740 (1996).
17. NEMUNAITIS, J., APPELBAUM, F.R., LILLEBY, K., BUHLES, W.C., ROSENFELD, C., ZEIGLER, Z.R., SHADDUCK, R.K., SINGER. J.W., MEYER, W. and BUCKNER, C.D., Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood, 83, 3473-3479 (1994).
18. PLANTE, M., RUBIN, S.C., WONG, G.Y., FEDERICI, M.G., FINSTAD, C.L. and GASTL, G.A., Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer, 73, 1882-1888 (1994).
19. TIBERGHIEN, P., LAITHIER, V., MABED, M., RACADOT, E., REYNOLDS, C.W., ANGONIN, R., LOUMI, R., PAVY, J.J., CAHN, J.Y., NOIR, A. and HERVÉ, P., Interieukin-1 administration before lethal irradiation and allogeneic bone marrow transplantation: early transient increase of peripheral granulocytes and successful engraftment with accelerated leukocyte, erythrocyte, and platelet recovery. Blood, 81, 1933-1939 (1993).
20. WARSHAW, A.L. and FERNANDEZ DEL CASTILLO, C., Pancreatic carcinoma. N. Engl. J. Med., 326, 455-465 (1992).